why choose us

Clinical Trials Search

Showing 15,110 of 132,963 result(s)
Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease

Status: ACTIVE_NOT_RECRUITING

Condition: GM2 Gangliosidosis

Interventions:

Pharmaceutical form: capsule

Route of administration: oral

Date: 2023-02-15

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions:

Patients will receive Neoadjuvant therapy with IPH5201 and durvalumab in addition to standard chemotherapy.

Following surgery, patients will

Date: 2023-02-15

NOLA GEM: Feasibility and Acceptability of an mHealth Intervention for Violence-affected PLWH

Status: Completed

Condition: HIV

Interventions: This is a mobile application that has 6 psychoeducational sessions and related skills, local resources, and a way for participants to track their prog

Date: 2023-02-15

Effects of Transportation Choices on Commuter Health

Status: Completed

Condition: Pollution; Exposure

Interventions:

Date: 2023-02-15

Mental Health Intervention Research in At-Risk Adolescents

Status: Completed

Condition: Mental Health Wellness 1

Interventions: Learning 2 BREATHE (L2B) is an empirically-supported, manualized mindfulness-based group program (Broderick, 2021).
Participants attend 6 session

Date: 2023-02-15

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Status: Completed

Condition: Tachycardia, Ventricular

Interventions: Subjects randomized to CRA will be treated with the Varian CRA system according to a uniform CRA protocol.
A dose of 25 Gy in a single fraction i

Date: 2023-02-15

Platelet Sub-study of the Neomindset Trial

Status: Completed

Condition: Acute Coronary Syndrome

Interventions: Acetylsalicylic acid (100 mg;day) + ticagrelor (90 mg twice daily) Or Acetylsalicylic acid (100 mg;day) + prasugrel (10 mg once daily)

Date: 2023-02-15

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

Status: Completed

Condition: Episodic Migraine

Interventions: Daylight Savings time transitions.

Date: 2023-02-15

Partners for Pain & Wellbeing Equity: A Randomized Trial of Community Supported Complementary and Integrative Health Self-management for Back Pain

Status: ACTIVE_NOT_RECRUITING

Condition: Neck Pain

Interventions:

Partners4Pain is a self-management program of evidence based complementary and integrative health approaches for pain including pain education, min

Date: 2023-02-15

Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)

Status: Completed

Condition: Phenylketonuria

Interventions: SYNB1934v1 IMP consists of powder for oral suspension packaged in sachets.
During dose preparation, the powder will be resuspended in water or ap

Date: 2023-02-15